CompletedPhase 3

Development of PHY606 as Adjunct Therapy for Anemia Patients

Taiwan39 participantsStarted 2017-08-22

Plain-language summary

Many reasons can cause anemia, decreased RBC production or increased destruction of circulation RBC. The investigators investigate the Danggui Buxue Tang (PHY606) composed of Angelicae Sinensis Radix and Astragali Radix in the fields of genomic and metabolomics in the healthy people and the patiens with anemia.

Who can participate

Age range

20 Years – 90 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * female: Hb\<11 g/dL; male: Hb\<13.5 g/dL * has no allergic reaction to TCM Exclusion Criteria: * below 20 years old * ever drug abuse or still in drug abuse * pregnant or in breast-feeding women * with psychotic disorders * cardiac arrhythmia with pacemaker * dyscoagulation or thrombocytopenia (platelet\< 15000/uL) or liver dysfunction (\> 2 fold normal range) * with severe disease (cardiac arrest, heart failure, COPD, GI bleeding, etc.) * under another clinical trials

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Constitution in Chinese Medicine Questionnaire (CCMQ)

Timeframe: Change from baseline CCMQ at Day0, Day31, Day93 and Day180.

Serum Cytokines

Timeframe: Change from baseline serum cytokines at Day0, Day31 and Day93.

Trial details

NCT IDNCT04974073

SponsorSheng-Teng Huang

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-08-22

View on ClinicalTrials.gov More Anemia trials